应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MXCT MaxCyte Inc
盘前交易 01-13 09:20:17 EST
1.36
-0.07
-4.90%
最高
1.43
最低
1.34
成交量
84.18万
今开
1.43
昨收
1.43
日振幅
6.29%
总市值
1.45亿
流通市值
1.31亿
总股本
1.07亿
成交额
115.56万
换手率
0.88%
流通股本
9,617万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
MaxCyte宣布2026年首席财务官过渡计划
投资观察 · 2025-11-20
MaxCyte宣布2026年首席财务官过渡计划
MaxCyte第三季度收入为640万美元，低于IBES预期的837万美元
投资观察 · 2025-11-20
MaxCyte第三季度收入为640万美元，低于IBES预期的837万美元
MaxCyte Inc宣布与Moonlight Bio达成战略平台许可协议，共同推进实体瘤T细胞疗法开发
美股速递 · 2025-10-06
MaxCyte Inc宣布与Moonlight Bio达成战略平台许可协议，共同推进实体瘤T细胞疗法开发
Maxcyte, Inc.盘中异动 急速拉升5.15%
市场透视 · 2025-09-06
Maxcyte, Inc.盘中异动 急速拉升5.15%
Maxcyte, Inc.盘中异动 快速下跌5.07%
市场透视 · 2025-08-12
Maxcyte, Inc.盘中异动 快速下跌5.07%
Maxcyte, Inc.盘中异动 股价大跌25.25%报1.53美元
市场透视 · 2025-08-07
Maxcyte, Inc.盘中异动 股价大跌25.25%报1.53美元
Maxcyte, Inc.盘中异动 下午盘股价大跌5.09%报2.15美元
市场透视 · 2025-07-30
Maxcyte, Inc.盘中异动 下午盘股价大跌5.09%报2.15美元
Maxcyte, Inc.盘中异动 快速下跌5.13%
市场透视 · 2025-03-11
Maxcyte, Inc.盘中异动 快速下跌5.13%
Maxcyte, Inc.盘中异动 下午盘股价大跌5.52%
市场透视 · 2025-02-27
Maxcyte, Inc.盘中异动 下午盘股价大跌5.52%
Maxcyte, Inc.盘中异动 早盘急速上涨5.31%
市场透视 · 2025-02-25
Maxcyte, Inc.盘中异动 早盘急速上涨5.31%
Maxcyte, Inc.盘中异动 下午盘股价大跌5.04%报3.96美元
市场透视 · 2025-02-19
Maxcyte, Inc.盘中异动 下午盘股价大跌5.04%报3.96美元
Maxcyte, Inc.盘中异动 早盘急速上涨5.41%
市场透视 · 2025-02-14
Maxcyte, Inc.盘中异动 早盘急速上涨5.41%
Maxcyte, Inc.盘中异动 股价大跌5.05%
市场透视 · 2025-02-12
Maxcyte, Inc.盘中异动 股价大跌5.05%
Maxcyte, Inc.盘中异动 股价大跌5.10%
市场透视 · 2025-02-03
Maxcyte, Inc.盘中异动 股价大跌5.10%
Maxcyte, Inc.盘中异动 股价大涨5.17%报4.88美元
市场透视 · 2025-01-30
Maxcyte, Inc.盘中异动 股价大涨5.17%报4.88美元
【纳斯达克生物科技指数收涨超1.6%】成分股Precigen收涨18.58%，阿玛琳涨16.17%，Grail涨14.71%表现第三、并领跑纳斯达克100指数的成分股。MaxCyte则收跌5.93%，跌幅第三大，10X Genomics跌8.65%，Pacific Biosciences of California跌8.84%。
金融界 · 2025-01-24
【纳斯达克生物科技指数收涨超1.6%】成分股Precigen收涨18.58%，阿玛琳涨16.17%，Grail涨14.71%表现第三、并领跑纳斯达克100指数的成分股。MaxCyte则收跌5.93%，跌幅第三大，10X Genomics跌8.65%，Pacific Biosciences of California跌8.84%。
Maxcyte, Inc.盘中异动 股价大跌5.14%报4.80美元
市场透视 · 2025-01-24
Maxcyte, Inc.盘中异动 股价大跌5.14%报4.80美元
Maxcyte, Inc.盘中异动 股价大涨5.05%
市场透视 · 2025-01-17
Maxcyte, Inc.盘中异动 股价大涨5.05%
Maxcyte, Inc.盘中异动 早盘股价大涨5.60%
市场透视 · 2025-01-15
Maxcyte, Inc.盘中异动 早盘股价大涨5.60%
Maxcyte, Inc.盘中异动 股价大跌5.30%报4.65美元
市场透视 · 2025-01-15
Maxcyte, Inc.盘中异动 股价大跌5.30%报4.65美元
加载更多
公司概况
公司名称：
MaxCyte Inc
所属市场：
NASDAQ
上市日期：
--
主营业务：
MaxCyte, Inc.于1998年7月31日根据特拉华州的法律和规定成立。该公司是一家领先的商业细胞工程公司，专注于提供支持平台技术，以推进基于细胞的创新研究以及下一代细胞治疗的发现、开发和商业化。在过去的二十年里，该公司开发了专有的Flow Electroporation平台并将其商业化，该平台促进了各种细胞的复杂工程。
发行价格：
--
{"stockData":{"symbol":"MXCT","market":"US","secType":"STK","nameCN":"MaxCyte Inc","latestPrice":1.36,"timestamp":1768251600000,"preClose":1.43,"halted":0,"volume":841759,"delay":0,"floatShares":96174451,"shares":106674011,"eps":-0.429946,"marketStatus":"盘前交易","change":-0.07,"latestTime":"01-13 09:20:17 EST","open":1.43,"high":1.43,"low":1.34,"amount":1155554.970574,"amplitude":0.062937,"askPrice":1.51,"askSize":10000,"bidPrice":1.28,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.429946,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768314600000},"marketStatusCode":1,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":1.36,"postHourTrading":{"tag":"盘后","latestPrice":1.39,"preClose":1.36,"latestTime":"19:50 EST","volume":5134,"amount":6985.7485,"timestamp":1768265446169},"volumeRatio":1.9324837464474662,"impliedVol":1.4534,"impliedVolPercentile":0.808},"requestUrl":"/m/hq/s/MXCT","defaultTab":"news","newsList":[{"id":"1196533798","title":"MaxCyte宣布2026年首席财务官过渡计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1196533798","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196533798?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:30","pubTimestamp":1763573428,"startTime":"0","endTime":"0","summary":"11月12日 - MaxCyte Inc：*MAXCYTE宣布2026年首席财务官过渡计划*MAXCYTE INC - 首席财务官DOUGLAS SWIRSKY将在2026年进行角色过渡*MAXCYTE INC - SWIRSKY将在任命继任者之前继续担任首席财务官","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","MXCT","BK4539"],"gpt_icon":0},{"id":"1163285225","title":"MaxCyte第三季度收入为640万美元，低于IBES预期的837万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163285225","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163285225?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:43","pubTimestamp":1763570621,"startTime":"0","endTime":"0","summary":"11月5日消息 - MaxCyte第三季度现金及投资总额为1.58亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"1196718221","title":"MaxCyte Inc宣布与Moonlight Bio达成战略平台许可协议，共同推进实体瘤T细胞疗法开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1196718221","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196718221?lang=zh_cn&edition=full","pubTime":"2025-10-06 20:06","pubTimestamp":1759752401,"startTime":"0","endTime":"0","summary":"MaxCyte Inc宣布与Moonlight Bio达成战略平台许可协议，共同推进实体瘤T细胞疗法开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MXCT","BK4121","BK4539"],"gpt_icon":0},{"id":"2565512516","title":"Maxcyte, Inc.盘中异动 急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565512516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565512516?lang=zh_cn&edition=full","pubTime":"2025-09-06 03:29","pubTimestamp":1757100564,"startTime":"0","endTime":"0","summary":"北京时间2025年09月06日03时29分，Maxcyte, Inc.股票出现波动，股价快速上涨5.15%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.05%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250906032925a7126452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250906032925a7126452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4121","MXCT"],"gpt_icon":0},{"id":"2558786667","title":"Maxcyte, Inc.盘中异动 快速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558786667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558786667?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:31","pubTimestamp":1754940681,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时31分，Maxcyte, Inc.股票出现异动，股价快速跳水5.07%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.30%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508120331219741657d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508120331219741657d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"gpt_icon":0},{"id":"2557984569","title":"Maxcyte, Inc.盘中异动 股价大跌25.25%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557984569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557984569?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:31","pubTimestamp":1754573513,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时31分，Maxcyte, Inc.股票出现异动，股价大幅跳水25.25%。截至发稿，该股报1.53美元/股，成交量20.4224万股，换手率0.19%，振幅10.54%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为1.21%。其相关个股中，Outset Medical, Inc.、银休特、齐默巴奥米特控股涨幅较大，Invo Fertility, Inc.、Ainos, Inc.、Tenon Medical, Inc.较为活跃，换手率分别为45.52%、10.32%、8.36%，振幅较大的相关个股有Invo Fertility, Inc.、Outset Medical, Inc.、Maxcyte, Inc.，振幅分别为23.98%、13.14%、10.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213153a6d8f9a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213153a6d8f9a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0},{"id":"2555065317","title":"Maxcyte, Inc.盘中异动 下午盘股价大跌5.09%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555065317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555065317?lang=zh_cn&edition=full","pubTime":"2025-07-30 01:42","pubTimestamp":1753810972,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日01时42分，Maxcyte, Inc.股票出现波动，股价快速下跌5.09%。截至发稿，该股报2.15美元/股，成交量10.5243万股，换手率0.10%，振幅5.53%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.24%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300142539725e41a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300142539725e41a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0},{"id":"2518546788","title":"Maxcyte, Inc.盘中异动 快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518546788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518546788?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:40","pubTimestamp":1741632016,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时40分，Maxcyte, Inc.股票出现波动，股价急速跳水5.13%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为1.64%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102401698a2d8b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102401698a2d8b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4121","MXCT"],"gpt_icon":0},{"id":"2514866134","title":"Maxcyte, Inc.盘中异动 下午盘股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866134?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:12","pubTimestamp":1740593537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时12分，Maxcyte, Inc.股票出现异动，股价急速下挫5.52%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.69%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702121896317881&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702121896317881&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0},{"id":"2514126090","title":"Maxcyte, Inc.盘中异动 早盘急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514126090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514126090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493874,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Maxcyte, Inc.股票出现异动，股价快速拉升5.31%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.05%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522311598924c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522311598924c4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","MXCT","BK4539"],"gpt_icon":0},{"id":"2512719648","title":"Maxcyte, Inc.盘中异动 下午盘股价大跌5.04%报3.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512719648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512719648?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:16","pubTimestamp":1739906209,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时16分，Maxcyte, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报3.96美元/股，成交量34.6713万股，换手率0.33%，振幅5.88%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.65%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031650988a2a64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031650988a2a64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0},{"id":"2511369488","title":"Maxcyte, Inc.盘中异动 早盘急速上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511369488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511369488?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:10","pubTimestamp":1739545855,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时10分，Maxcyte, Inc.股票出现波动，股价大幅上涨5.41%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.10%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231055962324a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231055962324a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0},{"id":"2510615332","title":"Maxcyte, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510615332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510615332?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:03","pubTimestamp":1739293432,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时03分，Maxcyte, Inc.股票出现波动，股价大幅跳水5.05%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.38%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212010352961f61b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212010352961f61b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"gpt_icon":0},{"id":"2508359142","title":"Maxcyte, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508359142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508359142?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:13","pubTimestamp":1738595637,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时13分，Maxcyte, Inc.股票出现波动，股价大幅跳水5.10%。截至发稿，该股报4.28美元/股，成交量10.2101万股，换手率0.10%，振幅2.00%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.68%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231357abc11094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231357abc11094&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4121","BK4539"],"gpt_icon":0},{"id":"2507621625","title":"Maxcyte, Inc.盘中异动 股价大涨5.17%报4.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621625?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:34","pubTimestamp":1738247685,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时34分，Maxcyte, Inc.股票出现异动，股价急速上涨5.17%。截至发稿，该股报4.88美元/股，成交量2.4515万股，换手率0.02%，振幅3.45%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.62%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302234459876b1ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302234459876b1ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2505024850","title":"【纳斯达克生物科技指数收涨超1.6%】成分股Precigen收涨18.58%，阿玛琳涨16.17%，Grail涨14.71%表现第三、并领跑纳斯达克100指数的成分股。MaxCyte则收跌5.93%，跌幅第三大，10X Genomics跌8.65%，Pacific Biosciences of California跌8.84%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505024850","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505024850?lang=zh_cn&edition=full","pubTime":"2025-01-24 05:50","pubTimestamp":1737669036,"startTime":"0","endTime":"0","summary":"成分股Precigen收涨18.58%，阿玛琳涨16.17%，Grail涨14.71%表现第三、并领跑纳斯达克100指数的成分股。MaxCyte则收跌5.93%，跌幅第三大，10X Genomics跌8.65%，Pacific Biosciences of California跌8.84%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/24055047770352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159837","BK4007","MXCT","BK4539","QID",".IXIC","PGEN","NVIW.SI","AMRN","BK4588","BK4139","BK4121","PSQ","ARTL","QLD","NQmain","BK1147","PACB","SQQQ","USAW.SI","TSYW.SI","NDX","TQQQ","03086","159632","MNQmain","USJW.SI","BK4585"],"gpt_icon":0},{"id":"2505499590","title":"Maxcyte, Inc.盘中异动 股价大跌5.14%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505499590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505499590?lang=zh_cn&edition=full","pubTime":"2025-01-24 01:28","pubTimestamp":1737653294,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日01时28分，Maxcyte, Inc.股票出现异动，股价大幅下跌5.14%。截至发稿，该股报4.80美元/股，成交量46.0469万股，换手率0.44%，振幅5.43%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.56%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124012815a22d2d8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124012815a22d2d8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"gpt_icon":0},{"id":"2504219877","title":"Maxcyte, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504219877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504219877?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:43","pubTimestamp":1737128603,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时43分，Maxcyte, Inc.股票出现异动，股价大幅拉升5.05%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.02%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172343239607a942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172343239607a942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2503640987","title":"Maxcyte, Inc.盘中异动 早盘股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503640987?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:40","pubTimestamp":1736952037,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时40分，Maxcyte, Inc.股票出现波动，股价大幅上涨5.60%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.72%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152240389604b6cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152240389604b6cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4539","MXCT"],"gpt_icon":0},{"id":"2503726505","title":"Maxcyte, Inc.盘中异动 股价大跌5.30%报4.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503726505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503726505?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:34","pubTimestamp":1736872496,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日00时34分，Maxcyte, Inc.股票出现异动，股价急速跳水5.30%。截至发稿，该股报4.65美元/股，成交量35.8864万股，换手率0.34%，振幅8.66%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.01%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011500345696039490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011500345696039490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maxcyte.com","stockEarnings":[{"period":"1week","weight":-0.1226},{"period":"1month","weight":-0.1053},{"period":"3month","weight":-0.1758},{"period":"6month","weight":-0.3585},{"period":"1year","weight":-0.6909},{"period":"ytd","weight":-0.1226}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MaxCyte, Inc.于1998年7月31日根据特拉华州的法律和规定成立。该公司是一家领先的商业细胞工程公司，专注于提供支持平台技术，以推进基于细胞的创新研究以及下一代细胞治疗的发现、开发和商业化。在过去的二十年里，该公司开发了专有的Flow Electroporation平台并将其商业化，该平台促进了各种细胞的复杂工程。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.050383},{"month":2,"riseRate":0.25,"avgChangeRate":-0.125224},{"month":3,"riseRate":0.5,"avgChangeRate":-0.044287},{"month":4,"riseRate":0.5,"avgChangeRate":-0.072674},{"month":5,"riseRate":0.25,"avgChangeRate":-0.06992},{"month":6,"riseRate":0.5,"avgChangeRate":-0.014501},{"month":7,"riseRate":0.5,"avgChangeRate":0.07388},{"month":8,"riseRate":0,"avgChangeRate":-0.149759},{"month":9,"riseRate":0.4,"avgChangeRate":-0.013093},{"month":10,"riseRate":0.2,"avgChangeRate":-0.034224},{"month":11,"riseRate":0.4,"avgChangeRate":0.098543},{"month":12,"riseRate":0.4,"avgChangeRate":-0.00509}],"exchange":"NASDAQ","name":"MaxCyte Inc","nameEN":"MaxCyte Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MaxCyte Inc(MXCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MaxCyte Inc,MXCT,MaxCyte Inc股票,MaxCyte Inc股票老虎,MaxCyte Inc股票老虎国际,MaxCyte Inc行情,MaxCyte Inc股票行情,MaxCyte Inc股价,MaxCyte Inc股市,MaxCyte Inc股票价格,MaxCyte Inc股票交易,MaxCyte Inc股票购买,MaxCyte Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MaxCyte Inc(MXCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}